SOMAVERT®
The importance of controlling IGF-I levels

SOMAVERT® (pegvisomant for injection) is a medicine used to treat acromegaly. SOMAVERT decreases the action of growth hormone (GH) and levels of IGF-I (Insulin-like Growth Factors) circulating in the blood. This helps control acromegaly.

SOMAVERT is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery and/or radiation therapy and/or other medical therapies, or for whom these therapies are not appropriate. The goal of treatment is to normalize serum IGF-I levels.

While you are on SOMAVERT, your doctor will check your IGF-I levels often. This will show how well your disease is controlled. Your doctor may change your dose to help you achieve normal IGF-I levels.

Understanding AcromegalyControlling IGF-I LevelsAbout SomavertFor Patients on SOMAVERTPfizer Bridge ProgramFAQs
Pfizer Bridge Program

Pfizer Bridge Program

Learn about patient support that can help improve access to treatment and insurance coverage.

Information for Healthcare Professionals

Find product and condition information, downloads, and support.